TABLE 4.

Fasting concentrations after 6 weeks of bezafibrate compared with placebo

	Placebo	Bezafibrate	P
Non-HDL-C (mmol/l)	3.53 ± 1.35	2.43 ± 0.96	0.0079a
TG (mmol/l)	2.60 (2.19–3.40)	1.50 (1.20–1.90)	0.0012a
TC (mmol/l)	4.78 ± 1.42	4.02 ± 0.91	0.0144a
HDL-C (mmol/l)	1.25 ± 0.32	1.38 ± 0.27	0.0017a
ApoB (g/l)	0.60 ± 0.17	0.49 ± 0.10	0.0020a
Glucose (mmol/l)	5.79 ± 0.77	5.74 ± 0.64	0.6796
Insulin (mIU/l)	12.0 (10.8–17.5)	9.9 (8.2–12.5)	0.0445a
HOMA-IR	3.1 (2.7–4.3)	2.9 (2.1–3.2)	0.1726
hsCRP (mg/l)	1.40 (1.05–3.10)	1.40 (0.95–2.40)	1.00

Data are expressed as mean ± SD or median (IQR).

^aP-value <0.05.